Epoxiconazole

CAS No. 133855-98-8

Epoxiconazole( BAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2 )

Catalog No. M27138 CAS No. 133855-98-8

Epoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 39 In Stock
25MG 70 In Stock
50MG 90 In Stock
100MG 146 In Stock
200MG 220 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epoxiconazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Epoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
  • Description
    Epoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    δ-opioid receptor| μ-opioid receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    133855-98-8
  • Formula Weight
    329.76
  • Molecular Formula
    C17H13ClFN3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (303.25 mM)
  • SMILES
    Fc1ccc(cc1)C1(Cn2cncn2)OC1c1ccccc1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mónica García, et al. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ 1 Receptor Antagonist Clinical Candidate for the Treatment of Pain. J Med Chem. 2020 Oct 16.
molnova catalog
related products
  • Benzoyleneurea

    Benzoyleneurea has anti-bacterial activity.?

  • Methicillin sodium

    Methicillin Sodium is the sodium salt form of methicillin a semisynthetic beta-lactam penicillin antibiotic with beta-lactamase resistant activity.

  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.